References
- Carragee EJ, Hurwitz EL, Weiner BK. (2011). A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J 11:471–491
- Chokshi D. (2007). Subchronic oral toxicity of a standardized white kidney bean (Phaseolus vulgaris) extract in rats. Food Chem Toxicol 45:32–40
- Ema M, Ito Y, Matsumoto M, et al. (2007). Screening study for repeated dose and reproductive/developmental toxicity of rubber accelerator, N,N-dicyclohexyl-2-benzothiazolesulfenamide, in rats. Drug Chem Toxicol 30:167–180
- Kim IS, Lee EN, Cho TH, et al. (2011). Promising efficacy of Escherichia coli recombinant human bone morphogenetic protein-2 in collagen sponge for ectopic and orthotopic bone formation and comparison with mammalian cell recombinant human bone morphogenetic protein-2. Tissue Eng Pt A 17:337–348
- Knox JB, Dai JM, 3rd Orchowski J. (2011). Osteolysis in transforaminal lumbar interbody fusion with bone morphogenetic protein-2. Spine (Phila Pa 1976) 36:672–676
- Kochanowska I, Chaberek S, Wojtowicz A, et al. (2007). Expression of genes for bone morphogenetic proteins BMP-2, BMP-4 and BMP-6 in various parts of the human skeleton. BMC Musculoskelet Dis 8:128
- Lee JH, Jang SJ, Koo TY, et al. (2011). Expression, purification and osteogenic bioactivity of recombinant human BMP-2 derived by Escherichia coli. Tissue Eng Regen Med 8:8–15
- Lee JH, Lee EN, Chang BS, Lee CK. (2014). Acute intravenous injection toxicity study of Escherichia coli-derived rh-BMP-2 in rat. Asian Spine J (accepted for publication)
- Lee JH, Ryu HS, Seo JH, et al. (2010). A 90-day intravenous administration toxicity study of CaO--SiO2--P2O5--B2O3 glass-ceramics (BGS-7) in rat. Drug Chem Toxicol 33:38–47
- Lee JH, Yu CH, Yang JJ, et al. (2012). Comparative study of fusion rate induced by different dosages of Escherichia coli--derived recombinant human bone morphogenetic protein-2 using hydroxyapatite carrier. Spine J 12:239–248
- Mackenzie SA, Lamb I, Schmidt J, et al. (2007). Thirteen week feeding study with transgenic maize grain containing event DAS-Ø15Ø7-1 in Sprague-Dawley rats. Food Chem Toxicol 45:551–562
- Magnuson BA, Appleton J, Ryan B Matulka RA. (2007). Oral developmental toxicity study of methysulfonulmethane in rats. Food Chem Toxicol 45:977–984
- Malley LA, Everds NE, Reynolds J, et al. (2007). Subchronic feeding study of DAS-591227 maize grain in Sprague-Dawley rats. Food Chem Toxicol 45:1277–1292
- Marshall MB, Draney D, Sevick-Muraca EM, Olive DM. (2010). Single-dose intravenous toxicity study of IRDye 800CW in Sprague-Dawley rats. Mol Imag Biol 12:583–594
- McNally AK, Macewan SR, Anderson JM. (2008). Foreign body-type multinucleated giant cell formation requires protein kinase C beta, delta, and zeta. Exp Mol Pathol 84:37–45
- Monteiro-Riviere NA, Linder KE, Inman AO, et al. (2012). Lack of hydroxylated fullerene toxicity after intravenous administration to female Sprague-Dawley rats. J Toxicol Environ Health A 75:367–373
- Otsuka F. (2010). Multiple endocrine regulation by bone morphogenetic protein system. Endocr J 57:3–14
- Owens K, Glassman SD, Howard JM, et al. (2011). Perioperative complications with rhBMP-2 in transforaminal lumbar interbody fusion. Eur Spine J 20:612–617
- Poynton AR, Lane JM. (2002). Safety profile for the clinical use of bone morphogenetic proteins in the spine. Spine 27:S40–S48
- Xuying W, Jiangbo Z, Yuping Z, et al. (2010). Effect of astragaloside IV on the general and peripartum reproductive toxicity in Sprague-Dawley rats. Int J Toxicol 29:505–516